세계 뼈성장 자극기 시장 규모는 2024년 22억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 34억 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 4.8%의 연평균 성장률(CAGR)을 보일 것으로 전망하고 있습니다. 이 시장은 사고 및 스포츠 외상, 노화로 인한 골절 증가, 사용자 친화적인 기기 시장 개척, 비침습적 치료 솔루션에 대한 선호도 증가 등을 배경으로 안정적인 성장세를 보이고 있습니다.
주요 시장 촉진요인 : 뼈성장 자극기 시장 전망에 따르면, 주요 촉진요인으로는 스포츠 관련 부상 증가, 뼈 유합 촉진 및 회복 시간 단축의 이점에 대한 인식, 전자기파 및 초음파 기반 자극기 시장 개척과 같은 급속한 기술 발전이 있습니다.
주요 시장 동향 : 뼈성장 자극기 시장 통계에 따르면, 주목할 만한 동향으로는 비침습적 치료로의 전환, 휴대용 및 사용자 친화적인 기기에 대한 수요 증가, 재생의료의 지속적인 발전 등이 있습니다.
지리적 동향 : 북미는 잘 구축된 의료 인프라의 존재로 인해 시장을 선도하고 있습니다. 그러나 아시아태평양은 환자들 사이에서 치료 솔루션 강화에 대한 관심이 높아짐에 따라 급성장하는 시장으로 부상하고 있습니다.
경쟁 상황 : 뼈성장 자극기 산업의 주요 시장 기업은 Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), Zimmer Biomet 등입니다.
도전과 기회 : 뼈성장 자극기 시장 개요에 따르면, 시장은 지속적인 연구 검증의 필요성과 같은 도전에 직면해 있습니다. 또한, 보다 진보되고 비용 효율적인 장치의 개발이라는 기회에도 직면해 있습니다.
골절 증가
골절의 증가로 인한 골성장 자극기의 채택 증가는 골성장 자극기의 용도에 긍정적인 영향을 미치고 있습니다. 골절은 사고나 스포츠 부상, 노화로 인한 골절 등 다양한 이유로 발생합니다. 세계보건기구(WHO)에 따르면 2,000만 명에서 5,000만 명이 교통사고로 치명적이지 않은 부상을 입어 골절이나 부상을 입어 효과적인 치료법이 필요합니다. 또한, 골밀도 감소로 인해 골절에 취약한 노인 인구의 골 성장 촉진제 채택이 증가함에 따라 시장 성장을 촉진하고 있습니다. 이와는 별도로, 뼈성장 자극기는 보다 빠르고 효과적인 뼈 치유를 위한 실행 가능한 솔루션을 제공하여 의료 전문가와 환자들 사이에서 선호되는 선택이 되고 있습니다. 또한, 환자들 사이에서 강화된 치료 솔루션에 대한 관심이 높아지면서 뼈성장 자극기 시장 기회가 증가하고 있습니다. 또한, 기존 골절 치료에 비해 빠른 회복과 통증 완화에 도움이 되기 때문에 점점 더 많은 사람들이 뼈성장 자극기를 선호하고 있습니다.
기술 발전
기술의 발전은 보다 진보되고 효율적이며 사용자 친화적인 장치의 개발을 지원하여 시장 성장에 기여하고 있습니다. 또한, 뼈 재생을 자극하기 위해 전자기장, 초음파, 펄스 전자기장(PEMF)과 같은 첨단 기술을 통합한 뼈성장 자극기의 사용이 증가하고 있는 것도 시장 성장에 긍정적인 영향을 미치고 있습니다. 이와는 별도로, 장비의 설계 및 기능의 개선은 치료 결과를 향상시킬 뿐만 아니라 환자의 순응도를 향상시킵니다. 또한, 환자가 일상 생활에 통합할 수 있도록 고도의 제어 기능을 갖춘 소형 휴대용 기기의 채택이 증가하고 있는 것도 뼈성장 시뮬레이터 시장 점유율을 뒷받침하고 있습니다. 이에 따라 의료 서비스 제공자는 환자를 위해 효과적이고 증거에 기반한 솔루션을 찾고 있습니다. 또한, 보다 효과적이고 매력적인 치료 옵션에 대한 대중의 수요가 증가함에 따라 시장 성장을 촉진하고 있습니다. 또한, 무선 연결 기능을 갖춘 첨단 뼈성장 자극기의 도입으로 의료 서비스 제공자는 환자의 순응도와 치료 진행 상황을 원격으로 모니터링할 수 있게 되었습니다. 예를 들어, Orthofix Medical Inc.는 뼈성장 자극기를 발전시키는 모바일 앱 버전 2.1 STIMonTrack의 미국 FDA 승인을 발표했습니다.
비침습적 치료 솔루션에 대한 선호도 증가
비침습적이고 고통스럽지 않은 치료 옵션에 대한 환자들의 수요가 증가함에 따라 뼈성장 자극기 시장의 수익이 증가하고 있습니다. 이에 따라 환자들은 수술이나 침습적 시술에 대한 대안을 찾고 있습니다. 또한, 뼈성장 촉진제는 뼈 치유를 위한 비수술적 대안을 제공합니다. 또한, 비침습적 치료는 환자의 불편함을 줄일 뿐만 아니라 합병증과 감염의 위험도 최소화할 수 있습니다. 이러한 이유로 뼈성장 자극기는 수술을 주저하거나 침습적 시술에 대한 금기 사항이 있는 환자 등 다양한 환자들에게 특히 매력적입니다. 이 외에도 비침습적 치료는 종종 회복 시간을 단축시켜 환자가 일상 생활을 더 빨리 재개할 수 있도록 도와줍니다. 또한, 환자 중심의 접근 방식에 대한 관심이 높아지면서 시장 성장을 촉진하고 있습니다. 또한, 비침습적 치료는 수술적 치료에 비해 비용 효율적이고, 병원 자원이 덜 필요하며, 입원 기간이 짧고, 전체 의료 비용을 절감할 수 있기 때문에 뼈성장 자극기 시장 가격에 긍정적인 영향을 미치고 있습니다.
The global bone growth stimulator market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is experiencing stable growth driven by the growing incidences of bone fractures due to accidents, sports injuries, and age-related factors, rising development of user-friendly devices, and increasing preferences for non-invasive treatment solutions.
Major Market Drivers: According to the bone growth stimulator market outlook, key drivers include the rising sports-related injuries, awareness about the benefits of accelerated bone healing and reduced recovery time, and rapid technological advancements, such as the development of electromagnetic and ultrasound-based stimulators.
Key Market Trends: Based on the bone growth stimulator market statistics, notable trends include the ongoing shift towards non-invasive treatments, growing demand for portable, user-friendly devices, and ongoing advancements in regenerative medicine.
Geographical Trends: North America leads the market, driven by the presence of well-established healthcare infrastructure. However, Asia Pacific is emerging as a fast-growing market due to the increasing focus on enhanced treatment solutions among patients.
Competitive Landscape: Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), and Zimmer Biomet, among many others.
Challenges and Opportunities: As per the bone growth stimulator market overview, the market faces challenges, such as the need for continuous research validation. It also encounters opportunities in developing more advanced and cost-effective devices.
Rising incidences of bone fractures
The growing adoption of bone growth stimulators due to rising incidences of bone fractures among individuals is positively impacting the uses of bone growth stimulator. In line with this, bone fractures can occur due to various reasons, such as accidents, sports injuries, and age-related factors. According to the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents, leading to fracturs and injuries that require effective treatment options. Moreover, the rising employment of bone growth stimulators among the geriatric population, as they are more prone to fracture issues due to reduced bone density, is propelling the growth of the market. Apart from this, bone growth stimulators offer a viable solution for quicker and more effective bone healing, making them a preferred choice among healthcare professionals and patients. In addition, the increasing focus on enhanced treatment solutions among patients is impelling the bone growth stimulator market opportunities. Furthermore, people are increasingly preferring bone growth stimulators, as they assist in faster recovery and reduced pain as compared to traditional fracture treatments.
Technological advancements
Technological advancements assist in the development of more advanced, efficient, and user-friendly devices, which is contributing to the market growth. In addition, the increasing use of bone growth stimulators that incorporate advanced technologies, such as electromagnetic fields, ultrasound, and pulsed electromagnetic fields (PEMF), to stimulate bone regeneration, is favoring the market growth. Apart from this, improved device design and functionality not only enhance treatment outcomes but also improve patient compliance. Furthermore, the rising adoption of smaller and portable devices with advanced control, as they allow patients to incorporate them into their daily routines, is supporting the bone growth simulator market share. In line with this, healthcare providers are seeking effective and evidence-based solutions for their patients. Additionally, the increasing demand for more effective and appealing treatment options among the masses is propelling the market growth. Moreover, the introduction of advanced bone growth stimulators that are equipped with wireless connectivity, enables healthcare providers to monitor patient compliance and treatment progress remotely. For instance, Orthofix Medical Inc announced U.S. FDA approval of mobile app version 2.1 STIMonTrack to advance bone growth stimulators.
Increasing preferences for non-invasive treatment solutions
The increasing demand for non-invasive and painless treatment options among patients is positively impelling the bone growth stimulator market revenue. In line with this, patients are increasingly seeking alternatives to surgery and invasive procedures. Additionally, bone growth stimulators provide a non-surgical option for bone healing. Furthermore, non-invasive treatments not only reduce patient discomfort but also minimize the risk of complications and infection. This makes bone growth stimulators particularly appealing to a broad spectrum of patients, including those who are hesitant about surgery or have contraindications for invasive procedures. Apart from this, non-invasive treatments often lead to shorter recovery times, allowing patients to resume their daily activities more quickly. Moreover, the rising focus on patient-centric approaches is bolstering the market growth. In addition, non-invasive treatments are more cost-effective as compared to surgical procedures, as they require fewer hospital resources, shorter hospital stays, and reduce overall healthcare expenses, which is positively influencing the bone growth stimulator market price.
Bone growth stimulation devices accounts for the majority of the market share
According to the bone growth stimulator market segment based on the product, bone growth stimulation devices hold the largest share. They are non-invasive medical instruments designed to promote the natural healing of bones. They work by delivering specific types of energy, such as electromagnetic fields, ultrasound waves, or electrical currents, to the site of the bone injury or fracture. In line with this, these devices are usually available in various forms, such as wearable braces, portable units, or implantable options. The choice of device depends on the nature and location of the fracture. They accelerate the production of bone-forming cells, such as osteoblasts, aiding in the repair and regeneration of damaged bone tissues.
Spinal fusion surgeries hold the largest share of the industry
According to the bone growth stimulator market trends, spinal fusion surgeries represented the largest market share. They involve joining two or more vertebrae in the spine to treat conditions like spinal instability, degenerative disc disease, or spinal fractures. In spinal fusion, bone growth stimulators play a critical role in promoting the fusion process. They stimulate bone healing at the surgical site, helping the vertebrae to fuse together more effectively and securely. The growing number of spinal-related conditions, along with the rising need for improved surgical outcomes, is positively impacting the future of bone growth stimulators.
Hospitals and clinics represent the leading market segment
As per the bone growth stimulator market segments, hospitals and clinics often use bone growth stimulators in various applications, including orthopedic surgeries, fracture management, and post-operative care. In hospitals, these stimulators are employed by orthopedic surgeons and in physical therapy departments to aid in the healing of bone fractures, spinal fusion procedures, and other orthopedic conditions. The institutional setting of hospitals and clinics ensures that patients receive expert care and guidance during the use of bone growth stimulators.
North America leads the market, accounting for the largest bone growth stimulator market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for bone growth stimulator.
According to the bone growth stimulator market trends, North America accounted for the largest market share due to the presence of well-established healthcare infrastructure, such as hospitals and clinics. In line with this, key players are developing advanced bone growth stimulator devices, which are bolstering the growth of the market in the region. Moreover, stringent regulatory frameworks for medical devices to ensure enhanced safety and efficacy are propelling the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), Zimmer Biomet, etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent reports analyzing how big is the bone growth stimulator market highlighted that key players in the industry are focusing on developing advanced bone growth stimulator devices by incorporating advanced technologies, improving device design, and enhancing treatment efficacy. In line with this, companies are conducting clinical trials to demonstrate the safety and effectiveness of their products. Moreover, they are expanding their product portfolios to offer a range of bone growth stimulator options, such as devices tailored as per specific applications, including spinal fusion or fracture healing, positively impacting the bone growth stimulator market price. Apart from this, manufacturers are collaborating with healthcare institutions, research organizations, and academic institutions to facilitate research, development, and the validation of bone growth stimulator technologies. Furthermore, they are working closely with regulatory authorities to obtain approvals and certifications for their devices.
February 13, 2020: Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that the U.S. Food and Drug Administration (FDA) approved the use of STIM onTrack mobile app version 2.1 with the bone growth stimulators of the company. The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes.
January 8, 2020: Medtronic Plc acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM(TM)) spinal cord stimulation. The therapy, which is delivered via the Medtronic Intellis platform, is a new and unique programming option to treat patients with chronic pain.
May 17, 2021: IGEA S.p.A. signed an exclusive license agreement with Orthofix Medical Inc. to commercialize overseas the range of innovative products dedicated to stimulation. In addition, the bone growth stimulation and joint preservation devices will be commercialized in the United States and Canada.